Seth Klarman - Baupost Group
As of Q2 2026, Seth Klarman reported 23 long-equity positions worth $5.42B in aggregate.
Copy-investor backtest
- Latest quarter
- +3.22%
- 1-year
- +20.94%
- 3-year
- +48.31%
- 5-year
- +12.01%
- 3-year vs S&P 500
- -25.70%
- 5-year vs S&P 500
- -61.90%
- 5-year top 5
- -0.29%
Return from mechanically copying the disclosed 13F equity portfolio after each filing and rebalancing at the next. The vs S&P 500 figures subtract SPY over that manager's own rebalance dates, so both sides cover the same days; both are price return, excluding dividends. Method & limitations.
Get email alerts when Seth Klarman files a new 13F — sign in or create a free account.
Updated 2026-06-06 from SEC 13F data.
Live quotes available for 14 of 35 rows. Rows without a quote are marked unavailable.
| 1 | LBTYK | LIBERTY GLOBAL PLC | 12.30% | Add +4.8% | 43,958,295 | $1.05B | $23.79 | No quote |
| 2 | VSAT | VIASAT INC | 12.17% | - | 13,732,068 | $1.03B | $75.32 | No quote |
| 3 | FOXA | FOX CORP | 10.14% | - | 27,322,720 | $861.62M | $31.54 | No quote |
| 4 | EBAY | EBAY INC | 7.63% | Reduce -31.1% | 16,646,000 | $648.86M | $38.98 | No quote |
| 5 | LNG | CHENIERE ENERGY INC | 7.52% | Reduce -5.0% | 10,139,133 | $639.37M | No quote | No quote |
| 6 | BMY | BRISTOL MYERS SQUIBB CO | 5.97% | Reduce -23.1% | 10,000,000 | $507.1M | $50.71 | No quote |
| 7 | CBS | CBS CORP NEW | 5.70% | Add +20.0% | 12,000,000 | $484.44M | No quote | No quote |
| 8 | QRVO | QORVO INC | 4.96% | Reduce -34.6% | 5,681,181 | $421.2M | $74.14 | No quote |
| 9 | CLNY | COLONY CAP INC NEW | 3.52% | - | 49,687,370 | $299.12M | No quote | No quote |
| 10 | PCG | PG&E CORP | 2.88% | - | 24,500,000 | $245M | $10.00 | No quote |
| 11 | NXST | NEXSTAR MEDIA GROUP INC | 2.41% | Add +43.1% | 2,000,000 | $204.62M | No quote | No quote |
| 12 | UNVR | UNIVAR SOLUTIONS INC | 2.32% | - | 9,500,000 | $197.22M | No quote | No quote |
| 13 | LBTYA | LIBERTY GLOBAL PLC | 2.23% | Add +2.9% | 7,657,205 | $189.52M | $24.75 | No quote |
| 14 | TBPH | THERAVANCE BIOPHARMA INC | 2.13% | - | 9,309,168 | $181.34M | No quote | No quote |
| 15 | FOX | FOX CORP | 2.11% | - | 5,680,307 | $179.16M | $31.54 | No quote |
| 16 | MCK | MCKESSON CORP | 2.10% | Reduce -49.7% | 1,306,011 | $178.48M | $136.66 | No quote |
| 17 | TBIO | TRANSLATE BIO INC | 2.03% | Add +98.4% | 17,544,239 | $172.23M | No quote | No quote |
| 18 | SYF | SYNCHRONY FINL | 2.01% | Reduce -46.0% | 5,003,981 | $170.59M | $34.09 | No quote |
| 19 | TAK | TAKEDA PHARMACEUTICAL CO LTD | 1.91% | Reduce -0.0% | 9,434,803 | $162.28M | $17.20 | No quote |
| 20 | NUAN | NUANCE COMMUNICATIONS INC | 1.58% | New | 8,245,456 | $134.48M | No quote | No quote |
| 21 | ATRA | ATARA BIOTHERAPEUTICS INC | 1.38% | Add +18.7% | 8,308,900 | $117.32M | No quote | No quote |
| 22 | COR | AMERISOURCEBERGEN CORP | 1.13% | Reduce -47.3% | 1,166,299 | $96.02M | No quote | No quote |
| 23 | AKBA | AKEBIA THERAPEUTICS INC | 1.13% | - | 24,471,453 | $95.93M | No quote | No quote |
| 24 | VRTV | VERITIV CORP | 0.76% | - | 3,564,439 | $64.45M | No quote | No quote |
| 25 | AR | ANTERO RES CORP | 0.75% | Reduce -26.2% | 21,087,791 | $63.69M | $3.02 | No quote |
| 26 | VIST | VISTA OIL & GAS S A B DE C V | 0.38% | New | 6,175,000 | $31.93M | $5.17 | No quote |
| 27 | CARS | CARS COM INC | 0.32% | New | 3,000,000 | $26.94M | No quote | No quote |
| 28 | TMQ | TRILOGY METALS INC NEW | 0.23% | Reduce -10.7% | 12,182,568 | $19.96M | No quote | No quote |
| 29 | GOSS | GOSSAMER BIO INC | 0.19% | Reduce -23.7% | 967,171 | $15.87M | No quote | No quote |
| 30 | PRTK | PARATEK PHARMACEUTICALS INC | 0.12% | - | 2,394,498 | $10.34M | No quote | No quote |
| 33 | XPO | XPO LOGISTICS INC | - | Sold | 0 | $0 | No quote | No quote |
| 32 | SBGI | SINCLAIR BROADCAST GROUP INC | - | Sold | 0 | $0 | No quote | No quote |
| 31 | AGN | ALLERGAN PLC | - | Sold | 0 | $0 | No quote | No quote |
Other instruments
Bonds, warrants, or non-share principal positions reported alongside the equity portfolio.
| 1 | TSLA 2.375 03/15/22 | TESLA INCNOTE 2.375% 3/1 | OTHER | 300,000,000 | $303.49M |
| 2 | TBPH 3.25 11/01/23 | THERAVANCE BIOPHARMA INCNOTE 3.250%11/0 | OTHER | 30,000,000 | $27.66M |